Jeffrey Bluestone, MD, PhD

University of California, San Francisco


As an international scientist and leader in the field of immunotherapy, Dr. Bluestone has helped characterize the body’s immune response on a molecular level and has catalyzed recent progress in stem cell research, islet cell transplantation, and immune tolerance therapies—studies that have been translated into drugs to treat human disease. He joined the University of California, San Francisco (UCSF) faculty in 2000, and holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Metabolism and Endocrinology. He is also Director of the Hormone Research Institute. In March 2010, he was appointed Executive Vice Chancellor and Provost to serve as Chief Academic Officer guiding the research and academic enterprise at UCSF, where he advanced the campus’s priorities in collaboration with the Chancellor and campus leadership. Dr. Bluestone has also served as the director of the UCSF Diabetes Center, where he emphasized translating basic research in both type 1 and type 2 diabetes into improved patient therapies. He founded and directed the Immune Tolerance Network, a consortium of more than 1,000 of the world’s leading scientific researchers and clinical specialists. In 2016, he was named President and CEO of the Parker Institute for Cancer Immunotherapy.

Go Back